Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tebaldi

Showing results (381-390 of 409) with videos related to

Pageof 41
Sort By:
JAMA Cardiology|August 29, 2025
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical TrialSimone Biscaglia, Andrea Erriquez, Vincenzo Guiducci, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Journal of Cardiovascular Pharmacology|July 19, 2024
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO RegistryAlessandro Sciahbasi, Salvatore De Rosa, Giuseppe Gargiulo, et al.
JAMA Cardiology|May 8, 2024
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical TrialAndrea Erriquez, Gianluca Campo, Vincenzo Guiducci, et al.
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trialFilippo Maria Verardi, Kamil Bujak, Paolo Tolomeo, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Synthesis of 1,2,3-Triazole-Containing Methoxylated Cinnamides and Their Antileishmanial Activity against the <i>Leishmania braziliensis</i> SpeciesFabíola Suelen Dos Santos, Rossimiriam Pereira de Freitas, Camila Simões de Freitas, et al.
Journal of the American College of Cardiology|August 31, 2025
Computed Tomography Angiography or Standard Care After Left Main PCI?Fabrizio D'Ascenzo, Enrico Cerrato, Ovidio De Filippo, et al.
REC, Interventional Cardiology|May 29, 2025
Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trialPablo Vidal-Calés, Kamil Bujak, Riccardo Rinaldi, et al.
The New Phytologist|December 13, 2024
Proper activity of the age-dependent miR156 is required for leaf heteroblasty and extrafloral nectary development in Passiflora sppJessica Ribeiro Soares, Kerly Jessenia Moncaleano Robledo, Vinicius Carius de Souza, et al.
Pageof 41

Showing results (381-390 of 409) with videos related to

Sort By:
Pageof 41
JAMA Cardiology|August 29, 2025
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction: Three-Year Outcomes of a Randomized Clinical TrialSimone Biscaglia, Andrea Erriquez, Vincenzo Guiducci, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Journal of Cardiovascular Pharmacology|July 19, 2024
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO RegistryAlessandro Sciahbasi, Salvatore De Rosa, Giuseppe Gargiulo, et al.
JAMA Cardiology|May 8, 2024
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk: A Randomized Clinical TrialAndrea Erriquez, Gianluca Campo, Vincenzo Guiducci, et al.
Open Heart|October 30, 2020
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trialOvidio De Filippo, Matteo Bianco, Matteo Tebaldi, et al.
Revista Espanola De Cardiologia (English Ed.)|July 28, 2023
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trialFilippo Maria Verardi, Kamil Bujak, Paolo Tolomeo, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Synthesis of 1,2,3-Triazole-Containing Methoxylated Cinnamides and Their Antileishmanial Activity against the <i>Leishmania braziliensis</i> SpeciesFabíola Suelen Dos Santos, Rossimiriam Pereira de Freitas, Camila Simões de Freitas, et al.
Journal of the American College of Cardiology|August 31, 2025
Computed Tomography Angiography or Standard Care After Left Main PCI?Fabrizio D'Ascenzo, Enrico Cerrato, Ovidio De Filippo, et al.
REC, Interventional Cardiology|May 29, 2025
Long-term prognostic impact of the left anterior descending coronary artery as the STEMI-related culprit vessel: subanalysis of the EXAMINATION-EXTEND trialPablo Vidal-Calés, Kamil Bujak, Riccardo Rinaldi, et al.
The New Phytologist|December 13, 2024
Proper activity of the age-dependent miR156 is required for leaf heteroblasty and extrafloral nectary development in Passiflora sppJessica Ribeiro Soares, Kerly Jessenia Moncaleano Robledo, Vinicius Carius de Souza, et al.
Pageof 41